This website uses cookies to enhance the user experience.
21st logo
||
N

NEUROZYM BIOTECH AS961 251 273

Limited company
Murbræk 7760 SNÅSA, Norge

NEUROZYM BIOTECH AS

Operating
Utvikle, produsere og selge naturbaserte produkter innen biologisk baserte områder. Selskapet skal også kunne involvere seg i beslektede områder, samt å delta i andre selskaper som driver slik virksomhet.

Organization

Chairman of the board
Years since formation
31 years
since Feb 20, 1995
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
200
1 share class
Total number of shareholders
4
persons
Belongs to group of

Financials

Total operating income 2025
100,000
NOK
Annual total result 2025
89,407
NOK
Total equity 2025
682,950
NOK
Last update: Aug 1, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO
12 %
directly

Board

NameRoleShares
Chairman
12 %
directly
Board Member
12 %
directly
Board Member
12 %
directly
Board Member-
Board Member
64 %
directly

Others

NameRoleShares
Accountant-

Top 10 individual shareholders

NameRoleShares
Board Member
64 %
directly
Managing Director/CEO, Board Member
12 %
directly
Chairman
12 %
directly
Board Member
12 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
128
64 %
Ordinary shares
24
12 %
Ordinary shares
24
12 %
Ordinary shares
24
12 %

Shares owned by the NEUROZYM BIOTECH AS

NameShare classTotal number of sharesShare
Z
ZYMBIO AS
Ordinary shares
18,366
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2025: NOK 100,000
    Operating profit 2025: NOK 47,581
    Employees: 0

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
100,000
0
0
359,944
583,932
Annual Total Result
89,407
983,759
-70,693
-58,097
113,001
Total assets
4,722,095
4,729,369
3,778,957
3,905,105
3,878,829
Total liabilities
4,039,145
4,135,825
4,169,172
4,224,627
4,140,255
Total equity
682,950
593,544
-390,215
-319,523
-261,426

P&L

Year20252024202320222021
Total operating income
100,000
0
0
359,944
583,932
Total operating costs
52,419
94,748
127,152
439,040
475,081
Operating result
47,581
-94,748
-127,152
-79,096
108,851
Financial income/costs
67,043
58,342
56,460
21,000
4,150
Profit before tax
114,624
-36,406
-70,693
-58,097
113,001
Total tax & extraordinary income/cost
25,217
-1,020,165
0
0
0
Annual Total Result
89,407
983,759
-70,693
-58,097
113,001

Balance overview

Year20252024202320222021
Total fixed assets
2,650,615
2,680,514
1,666,822
1,670,334
1,674,099
Total current assets
2,071,480
2,048,855
2,112,135
2,234,771
2,204,730
Total assets
4,722,095
4,729,369
3,778,957
3,905,105
3,878,829
Short term debt
34,173
34,173
34,634
66,636
114,249
Long term debt
0
4,101,652
4,134,539
4,157,991
4,026,006
Total liabilities
4,039,145
4,135,825
4,169,172
4,224,627
4,140,255
Contributed capital
1,191,791
1,191,791
1,191,791
1,191,791
1,191,791
Retained earnings
-508,841
-598,248
-1,582,006
-1,511,314
-1,453,217
Total equity
682,950
593,544
-390,215
-319,523
-261,426
Total equity and liabilities
4,722,095
4,729,369
3,778,957
3,905,105
3,878,829

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises